Neuphoria Therapeutics In... (NEUP)
NASDAQ: NEUP
· Real-Time Price · USD
6.89
-0.26 (-3.64%)
At close: Jun 06, 2025, 1:58 PM
-3.64% (1D)
| Bid | 6.89 |
| Market Cap | 12.95M |
| Revenue (ttm) | 15.66M |
| Net Income (ttm) | 5.74M |
| EPS (ttm) | 18.83 |
| PE Ratio (ttm) | 0.37 |
| Forward PE | -1.05 |
| Analyst | Strong Buy |
| Ask | 6.97 |
| Volume | 26,906 |
| Avg. Volume (20D) | 28,961 |
| Open | 7.26 |
| Previous Close | 7.15 |
| Day's Range | 6.67 - 7.35 |
| 52-Week Range | 2.12 - 12.55 |
| Beta | 0.46 |
About NEUP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NEUP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NEUP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
Neuphoria Therapeutics shares are trading higher a...
Unlock content with
Pro Subscription
1 week ago · https://www.marketscreener.com
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual MeetingBURLINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (“Neuphoria” or the “Company”), a clinical-stage biotechnology company developing impactful treatments fo...